ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.

<h4>Background</h4>Fibrillins 1 (FBN1) and 2 (FBN2) are components of microfibrils, microfilaments that are present in many connective tissues, either alone or in association with elastin. Marfan's syndrome and congenital contractural arachnodactyly (CCA) result from dominant mutati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gaynor Miller, Monica Neilan, Ruth Chia, Nabeia Gheryani, Natalie Holt, Annabelle Charbit, Sara Wells, Valter Tucci, Zuzanne Lalanne, Paul Denny, Elizabeth M C Fisher, Michael Cheeseman, Graham N Askew, T Neil Dear
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/095c5bd1ac0c4528b8de42f504717eeb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:095c5bd1ac0c4528b8de42f504717eeb
record_format dspace
spelling oai:doaj.org-article:095c5bd1ac0c4528b8de42f504717eeb2021-11-25T06:25:58ZENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.1932-620310.1371/journal.pone.0009137https://doaj.org/article/095c5bd1ac0c4528b8de42f504717eeb2010-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20161761/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Fibrillins 1 (FBN1) and 2 (FBN2) are components of microfibrils, microfilaments that are present in many connective tissues, either alone or in association with elastin. Marfan's syndrome and congenital contractural arachnodactyly (CCA) result from dominant mutations in the genes FBN1 and FBN2 respectively. Patients with both conditions often present with specific muscle atrophy or weakness, yet this has not been reported in the mouse models. In the case of Fbn1, this is due to perinatal lethality of the homozygous null mice making measurements of strength difficult. In the case of Fbn2, four different mutant alleles have been described in the mouse and in all cases syndactyly was reported as the defining phenotypic feature of homozygotes.<h4>Methodology/principal findings</h4>As part of a large-scale N-ethyl-N-nitrosourea (ENU) mutagenesis screen, we identified a mouse mutant, Mariusz, which exhibited muscle weakness along with hindlimb syndactyly. We identified an amber nonsense mutation in Fbn2 in this mouse mutant. Examination of a previously characterised Fbn2-null mutant, Fbn2(fp), identified a similar muscle weakness phenotype. The two Fbn2 mutant alleles complement each other confirming that the weakness is the result of a lack of Fbn2 activity. Skeletal muscle from mutants proved to be abnormal with higher than average numbers of fibres with centrally placed nuclei, an indicator that there are some regenerating muscle fibres. Physiological tests indicated that the mutant muscle produces significantly less maximal force, possibly as a result of the muscles being relatively smaller in Mariusz mice.<h4>Conclusions</h4>These findings indicate that Fbn2 is involved in integrity of structures required for strength in limb movement. As human patients with mutations in the fibrillin genes FBN1 and FBN2 often present with muscle weakness and atrophy as a symptom, Fbn2-null mice will be a useful model for examining this aspect of the disease process further.Gaynor MillerMonica NeilanRuth ChiaNabeia GheryaniNatalie HoltAnnabelle CharbitSara WellsValter TucciZuzanne LalannePaul DennyElizabeth M C FisherMichael CheesemanGraham N AskewT Neil DearPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 2, p e9137 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gaynor Miller
Monica Neilan
Ruth Chia
Nabeia Gheryani
Natalie Holt
Annabelle Charbit
Sara Wells
Valter Tucci
Zuzanne Lalanne
Paul Denny
Elizabeth M C Fisher
Michael Cheeseman
Graham N Askew
T Neil Dear
ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.
description <h4>Background</h4>Fibrillins 1 (FBN1) and 2 (FBN2) are components of microfibrils, microfilaments that are present in many connective tissues, either alone or in association with elastin. Marfan's syndrome and congenital contractural arachnodactyly (CCA) result from dominant mutations in the genes FBN1 and FBN2 respectively. Patients with both conditions often present with specific muscle atrophy or weakness, yet this has not been reported in the mouse models. In the case of Fbn1, this is due to perinatal lethality of the homozygous null mice making measurements of strength difficult. In the case of Fbn2, four different mutant alleles have been described in the mouse and in all cases syndactyly was reported as the defining phenotypic feature of homozygotes.<h4>Methodology/principal findings</h4>As part of a large-scale N-ethyl-N-nitrosourea (ENU) mutagenesis screen, we identified a mouse mutant, Mariusz, which exhibited muscle weakness along with hindlimb syndactyly. We identified an amber nonsense mutation in Fbn2 in this mouse mutant. Examination of a previously characterised Fbn2-null mutant, Fbn2(fp), identified a similar muscle weakness phenotype. The two Fbn2 mutant alleles complement each other confirming that the weakness is the result of a lack of Fbn2 activity. Skeletal muscle from mutants proved to be abnormal with higher than average numbers of fibres with centrally placed nuclei, an indicator that there are some regenerating muscle fibres. Physiological tests indicated that the mutant muscle produces significantly less maximal force, possibly as a result of the muscles being relatively smaller in Mariusz mice.<h4>Conclusions</h4>These findings indicate that Fbn2 is involved in integrity of structures required for strength in limb movement. As human patients with mutations in the fibrillin genes FBN1 and FBN2 often present with muscle weakness and atrophy as a symptom, Fbn2-null mice will be a useful model for examining this aspect of the disease process further.
format article
author Gaynor Miller
Monica Neilan
Ruth Chia
Nabeia Gheryani
Natalie Holt
Annabelle Charbit
Sara Wells
Valter Tucci
Zuzanne Lalanne
Paul Denny
Elizabeth M C Fisher
Michael Cheeseman
Graham N Askew
T Neil Dear
author_facet Gaynor Miller
Monica Neilan
Ruth Chia
Nabeia Gheryani
Natalie Holt
Annabelle Charbit
Sara Wells
Valter Tucci
Zuzanne Lalanne
Paul Denny
Elizabeth M C Fisher
Michael Cheeseman
Graham N Askew
T Neil Dear
author_sort Gaynor Miller
title ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.
title_short ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.
title_full ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.
title_fullStr ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.
title_full_unstemmed ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.
title_sort enu mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/095c5bd1ac0c4528b8de42f504717eeb
work_keys_str_mv AT gaynormiller enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT monicaneilan enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT ruthchia enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT nabeiagheryani enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT natalieholt enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT annabellecharbit enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT sarawells enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT valtertucci enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT zuzannelalanne enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT pauldenny enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT elizabethmcfisher enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT michaelcheeseman enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT grahamnaskew enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
AT tneildear enumutagenesisrevealsanovelphenotypeofreducedlimbstrengthinmicelackingfibrillin2
_version_ 1718413722514358272